-
E-mail
info@psi.bio
-
Phone
15873039282
-
Address
Chutian Science and Technology Industrial Park, Ningxiang Economic and Technological Development Zone, Changsha City, Hunan Province, China
Chutianpai Biotechnology (Changsha) Co., Ltd
How to achieve flexible synthesis routes for peptide synthesizers in the United States
Date: 2025-12-19Read: 0
American peptide synthesizerThrough modular architecture, precise fluid control, and diversified chemical strategies, we support a flexible synthesis route from research to production. Representative platforms such as PTI (Protein Technologies, Inc.) and CEM have developed mature solutions in terms of channel parallelism, method independence, chemical compatibility, and process enhancement. PTI's matrix valve system allows different reagents to be simultaneously and independently delivered to different reactors, and each channel can operate independently according to different scales and programs. It can even automatically cut and collect products in situ after synthesis is complete; CEM's Liberty microwave enhanced SPPS combines with a circular focused electromagnetic field to improve coupling/deprotection and cleavage efficiency, significantly shorten synthesis time, and enhance the purity of difficult peptides.
The first dimension of flexibility is multi-channel asynchronous parallelism and independent methods. For example, the PRELUDE 6-channel platform supports independent setting of reaction time and method for each channel, using bulk amino acids for on-demand preparation to reduce costs; Symphony X 24 channel and PurePep Chorus 2/4/6 channel can synthesize different sequences and scales in parallel, and can be configured with options such as UV monitoring and infrared heating; The PurePep Pathway system, combined with Single Shot transport, reduces dead volume and cross contamination, and enhances the stability of trace and long-chain peptide synthesis.
The second dimension of flexibility is chemical strategy and process reinforcement. The US platform generally supports the Fmoc/Boc dual strategy and provides in-situ/pre activation, multiple activators, and washing programs; Microwave enhancement can accelerate coupling and cyclization, shorten the synthesis cycle, and improve the purity of difficult sequences; Some platforms offer automatic in-situ cutting and a three in one (synthesis cutting purification) workflow to reduce manual transfer and exposure; In regulatory scenarios, Symphony X software supports 21 CFR Part 11 compliance (audit trail, permission management) to meet data integrity requirements.
For complex modification and high-throughput library synthesis, the US system achieves flexible production of "independent methods for each peptide and parallel execution of different sequences" through asynchronous multi-channel and high-throughput modules. For example, Tetra can synthesize up to 10 ^ 6 different peptides simultaneously, and each peptide can use its own preferred method; SOPHAS can cover hundreds of synthesizes in one operation and is compatible with multiple reactor specifications and materials, making it suitable for peptide library and process screening.
Implementation suggestion: First, determine the number and scale of channels based on the target (scientific research small-scale/pilot scale/library synthesis) and flux, and then select Fmoc/Boc and activation systems based on sequence difficulty (long chain, hydrophobic, containing special amino acids/modifications); Introduce microwave enhancement or elongation/double coupling for difficult to couple fragments; If multiple different methods need to be parallelized, priority should be given to models with asynchronous multi-channel and independent flow paths; Configure automatic cutting/purification and data compliance options throughout the entire process to improve reproducibility and delivery efficiency.